Indacaterol, a once-daily beta2 -agonist, versus twice-daily beta2 -agonists or placebo for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Indacaterol, a once-daily beta2 -agonist, versus twice-daily beta2 -agonists or placebo for chronic obstructive pulmonary disease

Published:2015-01-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Geake James B¹,Dabscheck Eli J²,Wood-Baker Richard³,Cates Christopher J⁴

Affiliation:

1. The Prince Charles Hospital; Department of Thoracic Medicine; Chermside Queensland Australia 4032

2. Alfred Hospital; Allergy Immunology and Respiratory Medicine; Melbourne Victoria Australia 3181

3. University of Tasmania; School of Medicine; Hobart Tasmania Australia 7001

4. St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE

Publisher

Wiley

Subject

Pharmacology (medical)

Reference48 articles.

1. Bateman ED Ferguson GT Barnes N Gallagher N Green Y Henley M Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study European Respiratory Journal 10.1183/09031936.00200212

2. Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD;Dahl;Thorax,2010

3. Magnussen H Paggiaro P Jack D Owen R Higgins M Kramer B Bronchodilator treatment with indacaterol once-daily vs formoterol twice-daily in COPD: a 52-week study American Thoracic Society International Conference; 2009 May 15-20 San Diego 2009

4. Magnussen H Paggiaro P Jack D Owen R Higgins M Kramer B Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD: a 52-week study European Respiratory Society 19th Annual Congress; 2009 Sep 12-15; Vienna 2009

5. Once-daily bronchodilators for chronic obstructive pulmonary disease;Donahue;American Journal of Respiratory and Critical Care Medicine,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The optimal dose of indacaterol for treatment of chronic obstructive pulmonary disease: a systematic review and Bayesian network meta-analysis;Journal of Thoracic Disease;2024-01

2. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-12-06

3. Impact of pharmacological and non-pharmacological interventions on mortality in chronic obstructive pulmonary disease (COPD) patients;Respiratory Medicine and Research;2023-11

4. Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Hospitalized Patients From Admission to Discharge: A Comprehensive Review of Therapeutic Interventions;Cureus;2023-08-18

5. Efficacy of acupuncture therapy for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis;Medicine;2023-04-14